Development and evaluation of a novel multiple-antigen ELISA for serodiagnosis of tuberculosis

Summary In this study, we describe the development and evaluation of a novel multiple-antigen ELISA for rapid diagnosis and screening of active tuberculosis (TB). The humoral immune responses of 136 active TB patients and 57 healthy subjects against antigens Rv3425, 38 kDa and lipoarabinomannan (LAM...

Full description

Saved in:
Bibliographic Details
Published inTuberculosis (Edinburgh, Scotland) Vol. 89; no. 4; pp. 278 - 284
Main Authors Zhang, Shu-Lin, Zhao, Jun-Wei, Sun, Zhan-Qiang, Yang, En-Zhuo, Yan, Ji-Huan, Zhao, Qi, Zhang, Guo-Long, Zhang, Hong-Mei, Qi, Yuan-Ming, Wang, Hong-Hai, Sun, Qing-Wen
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.07.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary In this study, we describe the development and evaluation of a novel multiple-antigen ELISA for rapid diagnosis and screening of active tuberculosis (TB). The humoral immune responses of 136 active TB patients and 57 healthy subjects against antigens Rv3425, 38 kDa and lipoarabinomannan (LAM) from Mycobacterium tuberculosis H37Rv were examined by ELISA. Three essential results were obtained. (i) Rv3425 antigen is a potential candidate for serodiagnosis of active TB. Of 136 active TB patients, Rv3425 antigen provided a sensitivity of 31.6%, lower than that of LAM antigen, but higher than that of 38 kDa antigen, with an overall specificity of 100%. (ii) For 62 smear-negative pulmonary TB patients and 15 extra-pulmonary TB patients, the multiple-antigen test provided a sensitivity of 43.5% and 26.7%, respectively, representing an improvement over acid-fast bacilli (AFB) smear-based diagnosis. (iii) Compared with the single-antigen ELISA and the two available commercial kits, the multiple-antigen test offered the highest accuracy (71.0%). In conclusion, the multiple-antigen ELSIA test based on Rv3425, 38 kDa, and LAM antigens is a potentially useful tool for the serodiagnosis and screening of active TB. Combinations of Rv3425 with other mycobacterial antigens may also be worthy of further investigation.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1472-9792
1873-281X
DOI:10.1016/j.tube.2009.05.005